HDAC9 and cancer: In the nucleus, butyrate and, to a lesser extent, propionate and acetate exert anti-carcinogenic effects via histone deacetylase (HDAC) inhibition, resulting in epigenetic changes and modified gene expression [88], leading to suppressed cancer cell proliferation and increased apoptosis [94,95,96,97] (Figure 2).